ECN Clinical leadership, business development professionals, and principal investigators will gather in Orlando to strengthen industry partnerships and highlight the network’s flexible approach to clinical research.
ORLANDO, FL – ECN Clinical, formerly Elite Clinical Network, announces its participation in the 2026 Society for Clinical Research Sites (SCRS) Global Site Solutions Summit, taking place October 15–18 at the Signia by Hilton Orlando Bonnet Creek in Orlando, Florida. Attendees are invited to connect with the ECN Clinical team at Booth #613 throughout the conference.
Celebrating its 20th anniversary, the SCRS Global Site Solutions Summit brings together clinical research sites, sponsors, contract research organizations (CROs), and industry leaders to address evolving challenges, share best practices, and strengthen collaboration across the clinical research ecosystem.
This year’s summit represents a significant milestone for ECN Clinical as the organization introduces its newly refreshed brand identity to the industry. The rebrand reflects the organization’s continued evolution, growing research capabilities, and commitment to delivering high-quality clinical trials through a connected, collaborative network.
Advancing Clinical Research Through a Flexible Site Network
ECN Clinical’s participation at SCRS underscores its commitment to building strategic partnerships and supporting efficient clinical trial execution.
Through its combination of embedded and standalone research sites, ECN Clinical offers sponsors and CROs a flexible approach to study placement, connecting clinical
development programs with experienced principal investigators and research teams positioned to meet specific protocol requirements.
The organization’s model emphasizes strategic site selection, streamlined study startup, operational efficiency, and collaboration across its network. By aligning the right investigators, sites, and resources with each study, ECN Clinical aims to deliver a more responsive and effective clinical research experience.
Meet the ECN Clinical Team at Booth #613
ECN Clinical will be represented by members of its executive leadership, business development, clinical operations, and principal investigator teams, providing attendees with an opportunity to connect directly with the professionals supporting research across the network.
Representatives attending the summit include:
· Christopher Brennan, Chief Executive Officer
· Melissa Faglie, Chief Operating Officer
· Chip Gillooly, Operating Partner and Chief Commercial Officer
· Nick Sanich, Vice President of Business Development
· Jason Biggs, Director of Business Development
· Sally Gibbens, Director, Quality & Training
· Roxana Rodriguez, MD, Principal Investigator, Noble Clinical Research
· Andrew Islas, Regional Site Director
· Michael Feldman, DO, Principal Investigator, Tropical Clinical Trials
Throughout the event, the team will engage with industry colleagues to discuss upcoming clinical development programs, explore opportunities for collaboration, and share insights into ECN Clinical’s capabilities across multiple therapeutic areas.
Introducing the Next Chapter of ECN Clinical
The 2026 summit coincides with the official introduction of ECN Clinical’s new corporate identity, formerly known as Elite Clinical Network.
Built around the principles of Excellence, Collaboration, and Nimbleness, the refreshed brand reflects the organization’s commitment to quality, meaningful partnerships, and adaptability in an evolving clinical research landscape.
Alongside the rebrand, ECN Clinical has launched a redesigned corporate website at www.ecnclinical.com, offering sponsors, CROs, investigators, and patients an enhanced view of its network, therapeutic expertise, and clinical research capabilities.
Attendees are encouraged to visit ECN Clinical at Booth #613 or schedule a meeting in advance by contacting bd@ecnclinical.com.
